Welcome to
Chemical Collective

Are you 18 or older?

Please confirm that your are 18 years of age or older.

You are not allowed to access the page.

I am 18+

EXIT

SALE NOW ON!

Microdosing Iboga: Why People Are Taking Tiny Amounts of a Hallucinogenic Shrub

By Martha Allitt

What is Iboga?
Intentional Microdosing of Iboga
A Stimulant for Hunters and Athletes
Mental Clarity and Present Awareness
Microdosing Iboga for Addiction
How Does Microdosing Iboga Compare to Other Psychedelics?
The Potential Downsides
Iboga is a Sacrament, Not a Microdosing Tool
Should We Be Microdosing Anyway?

8 minute read

0 Last updated November 28th, 2025

By Martha Allitt

Disclaimer: The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of Chemical Collective or any associated parties.

The iboga shrub has been revered for centuries by spiritual communities in West Africa. Today, ibogaine – the major chemical compound in iboga – is being recognized as a breakthrough treatment for addiction.

While mostly associated with large psychoactive doses, a growing number of individuals are exploring what benefits microdosing iboga may have to offer.

What is Iboga?

Tabernanthe iboga is an evergreen shrub native to West Africa. It has potent psychedelic properties, inducing dream-like visions and deep introspection. Bwiti, a spiritual tradition based in Gabon, has long valued iboga as a sacrament – using it for initiation and rites of passage. By connecting them to the spirit world, iboga serves as a tool for guidance, healing, and power.

Iboga’s main psychoactive compound, ibogaine, is becoming widely recognized as a powerful mental health treatment, particularly for addiction. Its anti-addictive properties were first discovered in the 1960s, when researcher and former heroin addict Howard Lotsof found it almost eliminated his cravings and withdrawal symptoms. Dr. Jean Loftus, an ambassador for Americans for Ibogaine, explains, “[I]t’s important to understand that ibogaine is not a cure for addiction. It’s an interrupter. It interrupts acute withdrawal; it interrupts post-addiction withdrawal syndrome; and it interrupts cravings.”

A wealth of clinical and anecdotal evidence has since highlighted ibogaine’s long-lasting benefits. Studies show it could be useful for a myriad of mental health conditions and diseases, from mood disorders to Parkinson’s Disease.

As research grows and more people become interested in iboga, numerous clinics are opening up in places where the medicine is legal. At the same time, an expanding network of healers is bringing the medicine back from Gabon and offering iboga in underground, Bwiti-style ceremonies.

Intentional Microdosing of Iboga

In a more niche trend, people are also taking small doses to help improve their well-being, energy, and cognition. This practice of microdosing is typically associated with psychedelics in the tryptamine chemical family, such as LSD and psilocybin. However, iboga – despite being in a completely different category of chemical compounds – appears to offer the same repertoire of benefits.

Sam Oliver, an independent iboga researcher, began exploring microdosing nearly a decade ago after being given a small bag of “exceptionally clean root bark” at a psychedelic conference. He has since begun creating a documentary about iboga and its various subcultures.

“I take it first thing in the morning on an empty stomach,” said Oliver. “I mix a pinch of sea salt into warm water, drink that, and then take the iboga. The salty water seems to steady the stomach, but also marks the ritual – the body waking up, the system priming itself.”

He explained that the ritual aspect is just as important as the dose. “If I’m working with iboga, even in small amounts, I want it to be deliberate. It’s not something I chuck in with my vitamins. The salt, the water, the breath, it sets the tone. It reminds me that I’m entering a relationship, not running a biohack.”

A Stimulant for Hunters and Athletes

One of the key effects Oliver notices with iboga is a marked increase in energy and a greater sense of attunement with his body. He feels more aware of his physical sensations, as if he were “in touch with all the elements of the body,” and finds he can run for much longer.

Oliver’s experience aligns with a purported use of small iboga doses in hunting.

“Traditionally, extracts of iboga have been used at low doses as a stimulant to prevent fatigue, hunger, and thirst among Africans during hunting trips,” an article in the Journal of Medicinal Chemistry states.

The statement may be an oversimplification, given the multilayered intricacies of hunting practices among followers of the Bwiti tradition and other Indigenous peoples. Yet, it’s clear people have long recognised the endurance-enhancing effects of small iboga doses.

In fact, when ibogaine was first isolated by French chemists, it was sold as a stimulant drug with the brand name Lambarene. The drug consisted of ibogaine extracts in doses that may now be considered a microdose. It was prescribed for people with depression and asthenia (general weakness), and became popular among post-World War II athletes to improve their performance. The International Olympic Committee banned Lambarene as a potential doping agent in the late 1960s.

Mental Clarity and Present Awareness

As well as physical benefits, microdosing iboga appears to induce a state of mental clarity and awareness.

“The main therapeutic thing for me is that it keeps me out of thought loops. There’s a wave of alertness, like I’m being pulled out of my daydreaming, or out of my thoughts,” said Johannes Walter, a civil servant.

Walter was introduced to iboga by a friend in Kenya and has been microdosing it for several years. Like Oliver, his microdoses aren’t true microdoses, at least according to definitions in which microdosing is meant to be “subperceptual” (without a noticeable effect). Walter consumes around half a gram of raw material in the morning, which he says has subtle effects and so is more like “minidosing.”

Walter described himself as “ADHD leaning,” finding it difficult to maintain attention and constantly seeking distractions. However, when microdosing iboga, he feels he has more patience and is less easily sidetracked.

”It’s not like I don’t get distracted, but my brain doesn’t seek out distraction as easily. I have more tolerance for situations that I’d otherwise see as boring or time-consuming.”

Unlike the tryptamines, Ibogaine blocks the reabsorption of dopamine, a chemical messenger molecule in the brain. Dopamine is responsible for feelings of pleasure, motivation, and focus, and a deficiency is thought to underlie ADHD symptoms. Microdosing ibogaine could potentially help restore this imbalance and potentiate a state of focus.

Microdosing Iboga for Addiction

Scientists think ibogaine’s effect on dopamine is also essential for its benefits in substance abuse recovery. From a neuroscience point of view, addiction develops when the brain’s reward system gets stuck in certain patterns. Ibogaine seems to boost dopamine at first, but then it makes those reward pathways less reactive, which may help “reset” the habits that drive addictive behavior.

There’s no concrete evidence to support that small doses create the same effect. Yet several Reddit users have said microdosing iboga has helped them break addictive habits.

“When I started microdosing with iboga at the beginning of this year, that jar of Kratom that I had home at the time suddenly got less and less interesting,” wrote one user. “The urge just disappeared. The Iboga tremendously helped with cravings AND with light withdrawal symptoms. It even made me drink less coffee, I just stopped wanting it.”

However, they warned iboga wasn’t a miracle cure, and the cravings reappeared once the microdosing cycle was over.

How Does Microdosing Iboga Compare to Other Psychedelics?

In addition to dopamine, iboga works on a multitude of other protein receptors in the brain. It activates a wide variety of chemical pathways, in contrast to the tryptamines, which have effects explained mainly by their action at the 5-HT2A receptor.

These distinct mechanisms help explain why microdosing iboga feels different from other psychedelics. People typically describe the experience of microdosing iboga as more grounded, focused, and less emotionally gripping.

“With things like mushrooms or LSD, even at very small amounts, one can get pulled so deeply into whatever emotional state is present that it becomes overwhelming rather than clarifying. It’s like you’re dropped inside the weather and the emotions are happening to you with very little distance. You can lose perspective because you’re so immersed,” said Oliver.

“Iboga is almost the opposite. It gives you this vantage point over a much wider emotional landscape. You can see all the different weather systems grief over here, anxiety over there, a bit of joy rolling in from somewhere else and you can watch how they move across you. You’re not dissociated, like with ketamine, but you’re not swallowed by it either. There’s space. You know you can step into a feeling if you need to and step back out again with far more ease.”

Another Reddit user similarly described this sense of being able to watch their thoughts and emotions with oversight. They wrote, “Iboga opens the heart, stabilizes and somewhat ‘rationalizes’ thought processes so you can safely detach from them.”

The Potential Downsides

Despite the myriad potential benefits, microdosing iboga is not without downsides.

People have reported feeling both more angry and anxious after microdosing iboga, especially when combined with caffeine. And while it can be stimulating for some, others have reported that microdosing makes them feel lethargic and sleepy.

Johanis described having somewhat of a “come-down” the day after microdosing. He said, “I sometimes feel a bit slow, maybe a bit cranky. In the sense that I think sometimes it takes a bit longer for everything to unfold. Coffee doesn’t quite do the job it normally does.”

A perhaps more crucial consideration is the cardiotoxic effects of iboga. Ibogaine interferes with the heart’s electrical signalling, triggering rapid and irregular heartbeats that can be fatal.

While smaller doses may carry less risk, one microdoser reported a concerning tightness in the chest that happened when microdosing iboga. Health experts strongly warn against using iboga along with any medication that affects the heart.

Iboga is a Sacrament, Not a Microdosing Tool

Regardless of any clinical risks, some people think iboga shouldn’t be microdosed at all because it’s a sacred medicine.

“Iboga (the medicine) and Bwiti (the tradition) are inseparable, so it’s not something I’d ever casually suggest or treat like a simple microdosing protocol,” said Carlotta Arsuro.

Arsuro is an event coordinator for the UK Psychedelic Society and founder of Carlotta PR. She took iboga for the first time at a retreat centre in Portugal and has since visited Gabon to do a full Bwiti initiation.

“Iboga is sacred with deep roots in Gabon, and the first time you work with it, it’s important to connect with the spirit of the medicine within the proper context and with respect for the Bwiti lineage that holds it.”

Darren LeBaron, an educator and independent researcher, holds a similar perspective. He highlighted how iboga and Bwiti are inseparable.

“Culturally, there is no such thing as iboga microdosing. There is no such thing even as an iboga ceremony,” he said. “Bwiti is part of a rich tradition with many rituals, of which iboga is a part, but it is not the whole thing.”

LaBaron believes that the real power of iboga is not revealed through its isolated effects, but rather, the whole container of Bwiti beliefs and rituals.

“We’re using these technologies for medicine, but they’re not medicines, they’re tools for communicating with the ancestors,” he said. “In the Western world, we have a missing relationship to the ancestors and to the spirit world, and this lost connection is what’s causing disease. While microdosing can patch up symptoms, it doesn’t address the root cause of what’s causing suffering in the first place.”

Should We Be Microdosing Anyway?

LeBaron described the whole microdosing trend, whether with iboga or other psychedelics, as a continuation of our “pill popping culture.”

“Although there are benefits of microdosing psychedelics, increasing neuroplasticity, and such, the evidence isn’t certain. What we do know, however, is that psychedelics can send you on a deep dive journey into the underworld. And these deep dives can be incredibly powerful.”

However, Labaron also noted that Western culture is afraid of the underworld, so microdosing is an “easy sell.”

High-dose psychedelic experiences can be deeply transformative, often reshaping how people see themselves and the world around them. After high doses of iboga, people typically feel more connected to nature, experience the aliveness of the universe, and feel a renewed sense of spirituality.

While these metaphysical threads fit within the culture of Gabon, they clash with the predominantly materialistic values of the West. Such a mismatch can leave people feeling disconnected from their homes, families, and social circles.

Microdosing offers a gentler approach. While it may not address what LeBaron noted as the root of suffering, perhaps it’s the necessary approach to engage with psychedelics. At least, if one wishes to remain in the ease of their current worldview.

Martha Allitt | Community Blogger at Chemical Collective

Martha is one of our community bloggers here at Chemical Collective. If you’re interested in joining our blogging team and getting paid to write about subjects you’re passionate about, please reach out to Sam via email at samwoolfe@gmail.com

share your toughts

Join the Conversation.

0 Comments

Inline Feedbacks

View all comments

9 minute read

In his book The Weird and the Eerie, cultural theorist Mark Fisher analyses the concept of the 'weird'. Sam Woolfe applies Fisher's analysis to psychedelic states.

09 Feb, 2026

Opinion | Psychedelics and Mark Fisher’s Theory of the Weird

Sam Woolfe

13 minute read

Un aperçu objectif du protoxyde d'azote, examinant sa normalisation croissante, ses effets puissants, son attrait, ses risques et son histoire.

07 Feb, 2026

Guides | Le gaz hilarant : Le protoxyde d’azote (N2O)

Nuit

13 minute read

Nuit compare les expériences de LSA issues de deux sources de semences, contextualisées par l'histoire et la science, dans le but de présenter une vision équilibrée des effets variables, des incertitudes, des risques et des enseignements de la LSA.

05 Feb, 2026

Personal Stories | Le LSA : la version naturelle du LSD ?

Nuit

12 minute read

Stroke, traumatic brain injury, and neurodegenerative diseases are leading, interconnected causes of global disability and economic burden with limited effective treatments. Sam Gandy highlights the potential of psychedelics as novel therapies to promote brain repair and recovery.

03 Feb, 2026

Science | Can Psychedelics Help Mend Broken and Ailing Brains?

Sam Gandy

11 minute read

The ancient, subterranean networks of fungi underpin life on Earth and are now emerging as a powerful foundation for future sustainable biotechnologies.

01 Feb, 2026

Science | Beyond the Trip: How Fungi Are Engineering Our Future

David Blackbourn

8 minute read

Dans la deuxième partie de ce guide sur l'influence du dosage sur les expériences psychédéliques, Eliacide examine les combinaisons de drogues et les expériences qui ne visent pas à dissoudre l'ego.

30 Jan, 2026

Guides | L’influence du dosage sur les expériences psychédéliques (Partie 2)

Eliacide

9 minute read

Eliacide explique que le dosage des médicaments est très subjectif et doit être choisi en fonction du niveau d'expérience personnel et du contexte souhaité, avertissant que les débutants doivent éviter les doses élevées et encourageant les individus à trouver leur propre « juste milieu » plutôt que de considérer tout conseil comme absolu.

28 Jan, 2026

Guides | L’influence du dosage sur les expériences psychédéliques (Partie 1)

Eliacide

9 minute read

Real-world data confirms the extremely low physical risk of psychedelics; the NHS and FDA intensify their scrutiny of clinical rollout; and we see expanding legal momentum in the US, as well as a shift towards shorter-acting compounds and even non-hallucinogenic, virtual alternatives.

26 Jan, 2026

All Articles | PSYCH NEWS – 26/01/2026

David Blackbourn

12 minute read

Nuit s'entretient avec Andrés Gómez, chercheur en conscience à l'Institut de recherche Qualia, qui fait le lien entre la science informatique, les récits expérientiels, les traditions contemplatives orientales et la recherche psychédélique.

25 Jan, 2026

Personal Stories | Mon échange avec le chercheur Andrés Gómez Emilson

Nuit

10 minute read

John Robertson offers a practical guide to understanding the causes of non-responses to psychedelics and what to do to move beyond them safely and effectively.

24 Jan, 2026

Guides | The ‘Nada’ Experience: What To Do When Psychedelics Don’t Work (Part 2)

John Robertson

7 minute read

Alfredo Squillaro argues that informed use, drug checking, and education are far more effective than stigma and repression in reducing the risks of psychoactive substance use.

22 Jan, 2026

Opinion | (Anti)prohibition, Psychonautics, and Designer Drugs

Alfredo Squillaro

11 minute read

Oli Genn-Bash reflects on the Western pursuit of an “authentic self,” using personal psychedelic experiences to question whether self-discovery is less about uncovering a fixed identity and more about cultivating a healthy relationship with the self that allows it to soften, open, and connect with others.

20 Jan, 2026

Self-Development | Discovering the Authentic Self Through Psychedelics

Oli Genn-Bash

9 minute read

Free parties can be understood as modern expressions of ancient ritual practices – akin to the Dionysian Mysteries – where music, dance, and psychoactive substances induce ecstatic states of consciousness.

18 Jan, 2026

Opinion | Dionysian Cults and Free Parties

Alfredo Squillaro

13 minute read

Nuit décrit son expérience du 2C-P comme un psychédélique puissant, à action lente et prolongée, appartenant à la famille des 2C-x – davantage comparable à une longue et exigeante randonnée qu'à un simple voyage.

16 Jan, 2026

Personal Stories | 2C-P : La charrette psychédélique

Nuit

11 minute read

Can psychedelics genuinely challenge and undermine the military-industrial complex by transforming consciousness, or do they risk being co-opted to merely help individuals psychologically adapt to an inherently violent and unjust system?

14 Jan, 2026

Opinion | Decentralised Minds: Can Psychedelics Undermine the Military Industrial Complex?

Oli Genn-Bash

11 minute read

Oli Genn-Bash explores the growing popularity of functional mushrooms, blending personal experience, research, and traditional perspectives to argue for a more holistic, respectful understanding of fungi.

12 Jan, 2026

Opinion | A Holistic and Spiritual Approach to Functional Mushrooms

Oli Genn-Bash

11 minute read

Despite bold promises surrounding psychedelics, a significant share of patients fail to meaningfully improve, revealing that non-response is a central – and often overlooked – challenge in psychedelic therapy.

10 Jan, 2026

Science | Let’s Talk About Non-Responders in Psychedelic Therapy

Ed Prideaux

8 minute read

Psychedelic use is commonly divided into spiritual, therapeutic, and recreational categories whose meanings are unclear and unevenly valued, with recreational use often stigmatised despite having aspects that deserve reconsideration.

08 Jan, 2026

Opinion | In Defence of Recreational Psychedelic Use

Annabelle Abraham

15 minute read

The Immortality Key builds a sweeping psychedelic-religion narrative on evidence that its own primary scientific authority later rejected as methodologically flawed, undermining the book’s credibility despite its popular success.

06 Jan, 2026

History | Psychedelic Bullshit? An Evaluation of The Immortality Key

Ed Prideaux

10 minute read

Over the past year, the psychedelic field has seen unprecedented scientific and regulatory advances collide with bureaucratic barriers and venture capital pressures, revealing both rapid progress toward medical integration and the fragility – and cultural tension – of an emerging industry at a pivotal moment.

04 Jan, 2026

News & Updates | PSYCH NEWS 2025 – THE YEAR IN REVIEW

David Blackbourn

8 minute read

Martha Allitt unpacks the history of MK-ULTRA, a secret CIA program that conducted unethical experiments with LSD, hypnosis, and other techniques in an attempt to develop methods of mind control and psychological manipulation during the Cold War.

04 Jan, 2026

History | MK-ULTRA: A Macabre History of LSD and Mind Control

Martha Allitt

16 minute read

Ed Prideaux examines Elon Musk’s alleged drug use and public behaviour in the context of his immense political and technological influence.

02 Jan, 2026

Opinion | High on Power: How Much Does Ketamine Explain Elon Musk’s Erratic Behaviour?

Ed Prideaux

10 minute read

Psychedelics can help us rethink the “hard problem” of consciousness by challenging the materialist view that the brain generates experience.

30 Dec, 2025

Philosophy | Psychedelics and the Hard Problem of Consciousness

David Blackbourn

12 minute read

Nuit décrit le 2C-C comme un membre subtil et apaisant de la famille 2C-X, qui évoque de doux souvenirs d'expériences sereines et introspectives.

28 Dec, 2025

Guides | 2C-C : la version Stone du 2C-B ?

Nuit

4 minute read

Theories suggest that N,N-dimethyltryptamine (DMT) is released in our brains when we die – but what do we really know about this potent psychedelic and its endogenous role in the human body?

22 Dec, 2025

Science | The Endogenous DMT Narrative: Separating Fact From Fiction

Stephanie Price

11 minute read

While psychedelics get most of the limelight in discussions about altered states of consciousness, such states can also be accessed through more accessible and potentially safer means, particularly sound baths.

20 Dec, 2025

Spirituality | Sound Baths and Altered States

Oli Genn-Bash

9 minute read

David Blackbourn explores the history and present-day use of psychoactive substances in the Middle East, including the religious, social, and political factors that have influenced this usage.

18 Dec, 2025

History | Contemporary Psychoactive Drug Use in the Middle East

David Blackbourn

5 minute read

Clinical trials typically evaluate psychedelics through short-term before-and-after measures to assess treatment efficacy, but longer-term and lifelong effects are harder to quantify.

14 Dec, 2025

Self-Development | The Long-Term Effects of Psychedelics Are Sometimes Ambiguous

Annabelle Abraham

11 minute read

While psychedelic insights may be valuable, they can be difficult to interpret and require a broader psychological, spiritual, philosophical, or cultural framework to determine whether they reflect genuine truth or mere subjective experience.

12 Dec, 2025

Self-Development | Psychedelics and Epistemic Authority: How Can We Trust Psychedelic Insights?

Oli Genn-Bash

11 minute read

John Robertson discusses the “nada experience,” a situation where psychedelics produce no noticeable effects, which can occur for various biological, psychological, and contextual reasons.

10 Dec, 2025

Guides | The ‘Nada’ Experience: When the Psychedelic Doesn’t Work (Part 1)

John Robertson

Our Products

Related Products

SALE! -35%

1V-LSD 150mcg Blotters From

(145)

1cP-LSD 100mcg Blotters From 18.00

(137)

Tryptamine Mix and Match Pack (4 x 0.1g) €65.00

(1)

SALE! -35%

1V-LSD 10mcg Micro Pellets From

(44)

SALE! -35%

1V-LSD 225mcg Art Design Blotters From

(62)

1S-LSD 150mcg Blotters From 29.00

(18)

1cP-LSD 150mcg Art Design Blotters From 25.00

(74)

SALE! -35%

1V-LSD 225mcg Pellets From

(26)

1cP-LSD 10mcg Micro Pellets From 15.00

(23)

1D-LSD 225mcg Pellets (1T-LSD) From 42.00

(13)

5-MeO-DMT Freebase From 23.95

(36)

1S-LSD 10mcg Micro Pellets €20.00

(3)

O-PCE HCL From 17.50

(25)

1cP-LSD 20mcg Micro Blotters From 18.00

(28)

1cP-LSD 150mcg Pellets From 25.00

(13)

see all products

Earn
Affiliates

Welcome to Chemical Collective.

Create an account to earn 200 welcome points.

create account

Already have an account? Sign in

Comment on an article

50

Check out our Community Blog and get involved with the conversation. You will be awarded 50 x ChemCoins for each comment up to a limit of 250 total ChemCoins.
Leave a product review

50

Have you purchased any of our products? Reviews and reports are so important to the community. Share your honest opinion, and we’ll reward you with 50 ChemCoins for each review!
Complete an order

X

Every time you complete an order with us, you’ll be awarded ChemCoins for each Euro spent.

Welcome to Chemical Collective.

Create an account to earn 200 welcome points.

create account

Already have an account? Sign in

Become an affiliate!

Earn commission every time someone makes a purchase through your link.

When you become an affiliate, you will be allocated a unique link to share with your friends, followers, subscribers, or Aunt Susan.

You can choose to payout the commission earned once per month, or save it up to receive on a rainy day! Commission earned is 5% of the total order value per referral.

Contact us to join the Chemical Collective family and become an affiliate.

Welcome toChemical Collective

Microdosing Iboga: Why People Are Taking Tiny Amounts of a Hallucinogenic Shrub

By Martha Allitt

in this article

By Martha Allitt

What is Iboga?

Intentional Microdosing of Iboga

A Stimulant for Hunters and Athletes

Mental Clarity and Present Awareness

Microdosing Iboga for Addiction

How Does Microdosing Iboga Compare to Other Psychedelics?

The Potential Downsides

Iboga is a Sacrament, Not a Microdosing Tool

Should We Be Microdosing Anyway?

By Martha Allitt

share your toughts

Join the Conversation.

Related articles

Related Products

Reward program

Comment on an article

Leave a product review

Complete an order

Become an affiliate!

Welcome to
Chemical Collective